Synthetic but Not Realistic: The Evaluation Challenge in Generative Modelling for Structured Electronic Medical Records
Summary
A new multi-dimensional evaluation framework addresses the challenge of assessing synthetic healthcare data, which is often proposed as a privacy-preserving substitute for real patient information. Current evaluation methods, focused on statistical similarity and predictive performance, fail to capture clinical validity. This framework, grounded in epidemiology, evaluates descriptive fidelity, clinical utility, and structural validity, corresponding to descriptive, predictive, and causal questions. Evaluating four generative paradigms—GAN-based, VAE-boosted, diffusion-based, and masked modelling—on the 50,000-person PRIME-CVD cohort revealed that while models reproduce marginal distributions, none simultaneously preserve subgroup structure, effect estimates, and dependency structure. Critically, strong distributional fidelity can mask poor calibration and distorted relationships, leading to unreliable inference and overestimating synthetic data quality.
Key takeaway
For data scientists and researchers generating or utilizing synthetic electronic medical records, relying solely on statistical similarity or predictive performance metrics is insufficient. You should integrate a multi-dimensional evaluation framework that assesses descriptive fidelity, clinical utility, and structural validity. This approach ensures your synthetic data accurately reflects complex clinical relationships and supports valid scientific conclusions, preventing overestimation of data quality and unreliable downstream inference.
Key insights
Current synthetic healthcare data evaluation methods overlook clinical validity, leading to unreliable inferences.
Principles
- Clinical validity requires multi-dimensional assessment.
- Distributional fidelity does not guarantee reliable inference.
- Domain-informed evaluation is crucial.
Method
A multi-dimensional evaluation framework assesses descriptive fidelity, clinical utility, and structural validity, addressing descriptive, predictive, and causal questions in epidemiology.
In practice
- Adopt a multi-dimensional evaluation framework.
- Assess subgroup structure and effect estimates.
- Prioritize clinical utility over statistical similarity.
Topics
- Synthetic Data
- Electronic Medical Records
- Generative Models
- Data Evaluation
- Clinical Validity
- Epidemiology
- PRIME-CVD
Best for: AI Architect, CTO, VP of Engineering/Data, AI Scientist, Research Scientist, Data Scientist
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Takara TLDR - Daily AI Papers.